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Abstract 
Antibiotic resistance is a constantly progressing epidemic. Many strains of bacteria have 
developed a resistance to antibiotics, resulting in prolonged sickness and death. Resistance can be to a 
specific drug (single drug resistance) or to multiple drugs (multi-drug resistance). This resistance can be 
caused by a tripartite protein pump called an efflux pump that extends through the inner and outer 
membranes of the bacterium to pump antibiotics from the inside of the cell to the extracellular 
environment. In E. coli the efflux pump is called AcrAB-TolC. In the efforts to combat this problem, this 
experiment focuses on the inactivation of the AcrAB-TolC pump via organic compounds extracted from 
edible plants. Extracts from plants, nuts, and roots will be tested for their ability to inhibit the bacterial 
efflux pump. I hypothesize that naturally occurring compounds can block the activity of this pump and 
combat antibiotic resistance. 
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I. Introduction
Antibiotic Resistance
           Antibiotic resistance is becoming the center of public health concerns worldwide 
(Swick). In the United States, 2 million people acquire an infection of resistant bacteria 
per year. At least 23,000 people die as a result of these resistant infections, and many 
more die due to complications (CDC). Bacteria can develop resistance to specific drugs 
(specific drug resistance, SDR) or to multiple drugs (multi-drug resistant, MDR). MDR 
bacteria are defined as being resistant to three or more classes of antibiotics (Swick). 
Resistance to antibiotics can be caused by many factors. One of the most significant 
factors is the over-prescribing of antibiotics. Prescribing antibiotics that are not necessary 
or not effective are some of the biggest contributing factors to resistance. Antibiotics used 
for livestock are also a major contributor (CDC).  Livestock are given antibiotics in the 
efforts to prevent, control, or treat a disease, as well as promote growth. The Food and 
Drug Administration has taken steps to reduce the amount of antibiotics used in food 
production because they have not been found to be necessary (CDC). The safe and 
appropriate usage of antibiotics is important in combating this issue. 
Bacterial Efflux Pumps 
Multidrug resistance can be caused by many mechanisms, but a common 
mechanism is the bacterial efflux pump. The efflux pump is an energy-dependent 
transporter that spans from the inner to the outer membrane of gram-negative bacteria. 
These efflux pumps are not specific to the compounds they can transport, and they can 
therefore confer resistance to many different types of antibiotics (Marquez, 2005). These 
MDR pumps can be broken into two different types of transporters: Primary (or ABC) 
and Secondary (see Figure 1). 
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Figure 1: Figure reproduced from: Du et. al, 2018. Above is an illustration of the different types of efflux pumps present in 
gram negative bacteria. This shows the multiple types of mechanisms that can be used for MDR. The two pumps on the far 
right are the pumps of concern. For this experiment, the RND family was observed, specifically the AcrAB-TolC efflux 
pump (second from the right). A more detailed picture can be seen in Figure 2. 
 
Primary transporters utilize ATP as their energy source, giving them the name 
ATP-binding cassette (ABC) transporters. Secondary transporters utilize an 
electrochemical gradient to generate energy to operate the pump. This type of pump is 
seen primarily with MDR transporters. Secondary transporters are broken into four 
different families: major facilitator superfamily (MFS), resistance nodulation and cell 
division (RND), small multidrug resistance (SMR), and multidrug and toxic compound 
extrusion (MATE) families (Marquez, 2005). The RND efflux systems are major 
contributors to antibiotic resistance and are particularly prevalent in E. coli bacteria 
(Marquez, 2005). 
AcrAB-TolC Protein Complex 
Gram-negative bacterial membranes are comprised of three layers. There is an 
inner membrane, periplasm, and an outer membrane. This membrane system provides the 
cell with a permeability barrier that contributes to the greater resistance found in gram-
negative bacteria compared to gram-positive bacteria (Starvi). E. coli, a common gram-
negative bacteria, utilizes the AcrAB-TolC system (Marquez, 2005). The membrane 
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transport provided by the AcrAB-TolC efflux pump is achieved by a three complex 
system, as illustrated below (Figure 2).  
  
 
                         
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2 An illustration of the three-protein structure that spans the entire membrane and allows efflux out of the cell. 
This figure is an expanded view of the complex. In vivo the proteins would be in contact with one another. TolC is the exit 
protein that faces the extracellular matrix (long cylindrical protein). The inner protein, AcrB, collects compounds from the 
inside of the cell and the periplasm to be pumped out (bell shaped protein on the bottom). AcrA resides in the periplasm 
and serves as an adaptor protein that links AcrB to TolC. 
 
The first complex is the inner membrane protein. The inner membrane protein, 
more widely recognized as AcrB, is energized by the proton motive force. The proton 
motive force is a charged gradient created at the membrane from the electron transfer 
chain. AcrB is followed by the second complex in the efflux system known as the 
membrane fusion protein, or AcrA. This protein changes conformation to create an iris-
like mechanism that spans the periplasm and allows the outer membrane factor to open 
and close (Mikolosko, Bobyk, Zgurskaya, & Ghosh, 2006). The third and final 
component is the outer membrane factor. This protein, TolC, is a cylindrical channel 
leading to the extracellular space. The TolC protein is nondiscriminatory and can 
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transport anything to the extracellular space. These three complexes make up the RND 
membrane transport efflux pump used by Gram-negative bacteria for MDR.  
Efflux Pump Inhibitors 
            Pump function can be altered by an efflux pump inhibitor. Inhibition can happen 
by a variety of mechanisms; disturbance of pump assembly, depletion of the energy 
source, inhibition of enzymes which maintain the proton motive force, blockage of the 
efflux channel, or alteration of genes (Prasch & Bucar, 2015). Any of these mechanisms 
can cause a decrease in the function of the pump.  Efflux pump inhibitors (EPIs) can 
significantly decrease the minimum inhibitory concentration (MIC) of a cell. The MIC is 
the lowest concentration of an antimicrobial agent that prevents visible growth of a 
microorganism. An EPI should decrease the MIC of an antibiotic by decreasing drug 
efflux (Prasch & Bucar, 2015). MDR systems are not fully understood, but the EPIs are 
thought to bind directly to or act as substrates for the efflux pump. Through this action 
they can inhibit by ATP-binding, disturbing the proton motive force, or compete with 
antibiotics for pump access and result in antibiotic accumulation within the cell 
(Marquez, 2005).  
            I hypothesize that plants might produce compounds that can block bacterial efflux 
pumps and enhance the sensitization of bacterial cells to antibiotics. Plants have served as 
a pharmaceutical source since the beginning of medicine (Prasch & Bucar, 2015). 
Aspirin, a common anti-inflammatory drug, is derived from willow tree bark (Foster & 
Duke, 286). Native Americans discovered many plants, such as ginger, clover, or garlic, 
that served as interventions for various ailments at the time (Foster & Duke, 30). Many 
plants still serve medicinal purposes, including many antibacterial products. Plants have 
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to protect themselves from harmful bacteria and pathogens by providing self-produced 
antibacterial compounds to fend off infection and instill survival. To test my hypothesis, I 
will use plant extracts in a fluorescence indicated efflux assay to measure the 
accumulation of EtBr within the cell to determine inhibition of live E. coli cells. 
II. Materials and Methods 
A. Extracting natural compounds 
Plant materials were purchased from Whole Foods (Miamisburg, OH), washed, 
cut into small pieces, and dried in plastic weigh dishes in an open incubator at room 
temperature with the incubator’s fan running. Once dry, the foods were chopped further 
and ground with a mortar and pestle. The powders were weighed, placed in glass vials, 
and stored -80 degree Celsius. 
Natural compounds were heat extracted using a Soxhlet extractor (Figure 3). 
Methanol was placed in the round bottom flask and secured to a ring holder. This was 
then attached to the extraction chamber. A paper thimble was filled with the dried and 
processed food before the condenser was attached. The heating mantle was adjusted to 
bring the methanol to a gentle boil and the mechanism was left untouched for 24 hours, 
or until the liquid filling the Soxhlet chamber was clear and the remaining liquid in the 
round bottom flask was colored. The Soxhlet chamber extracted the natural compounds 
by boiling the methanol in the round bottom flask and allowing the liquid to vaporize. 
This vapor travelled through the chamber and into the condenser. When it reached the 
condenser it condensed and dripped through the thimble in the chamber. This chamber 
filled up with warm methanol, allowing the thimble to steep in it until the arm released 
the liquid back into the round bottom flask and the whole process repeated. The 
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extraction was considered complete when the methanol filling the chamber had run 
colorless and the liquid in the round bottom flask was strongly pigmented. The 
compounds remaining in the round bottom flask were placed in a 50 mL centrifuge tube 
at room temperature and set under a steady stream of compressed air to dry. Once dried, 
the tubes were stored at -80 degree Celsius until testing. 
            The natural compounds were also extracted through a room temperature methanol 
extraction that did not involve the Soxhlet extractor, but instead used centrifuge tubes. 
The grams per milliliter concentrations were calculated from the heat extractions and 
used to create the same concentration of compound in the cold extractions. The proper 
amount of compound was added to 50mL of methanol and the tube was covered in 
parafilm. The centrifuge tubes were then placed on an orbital shaker for 24 hours. After 
24 hours the solution was passed through filter paper and left to dry on large watch 
glasses. Once the solutions dried they were scraped using 3 mL of milliQ water and 
stored in a 15 mL centrifuge tube until testing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: An illustration of the Soxhlet Extractor used to collect organic compounds from plant materials. Methanol was 
added to the boiling flask, the produce was added to the thimble in the Soxhlet chamber, and water was run through the 
condenser. 
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B. Room Temperature Methanol Extractions 
The natural compounds were also extracted through a room temperature methanol 
extraction that did not involve the Soxhlet extractor, but instead used centrifuge tubes. 
The grams per milliliter concentrations were calculated from the heat extractions and 
used to create the same concentration of compound in the cold extractions.  
The mass of the produce before extraction in hot methanol was taken and divided 
by 100. This provided a grams per mL measurement. I then tarred this much produce and 
placed it in a 50 mL centrifuge tube with 50 mL of methanol. The top was sealed with 
parafilm to secure the lid and prevent leaking. These tubes were secured in a bin and 
placed on the orbital shaker at maximum speed for 24 hours. The tubes were then 
removed and the contents were strained through a Kimwipe onto a large glass 
evaporating dish in the fume hood. This was left to dry. Once dried 3 mL of milliQ water 
was used to scrape the contents into a 15 mL centrifuge tube and stored at -80 degree 
Celsius until testing. 
C. Ethidium bromide efflux assay 
An efflux assay with the fluorescent indicator ethidium bromide (EtBr) was 
performed using AG100 E. coli cells. This assay allows the efflux of live cells to be 
measured by fluorescence measurements. This assay was derived from a method 
proposed by Coldham et al for an ethidium bromide accumulation assay (Coldham et al, 
2010). To perform this assay, AG100 E. coli cells were inoculated into 3 mL of LB and 
incubated at 37 degrees Celsius overnight. The inoculated cells were then diluted in 25 
mL of LB to and OD600 of 0.400. The cells were incubated at 37 degrees Celsius until 
they reached an OD600 of 0.600. Six centrifuge tubes were collected and filled with 1 
Page  | 11 
mL of cells. These cells were centrifuged for 60 seconds at 15,000 rpm. The supernatant 
was removed and the cells were washed with phosphate buffered saline (PBS). This 
process was repeated once more. After the third and final centrifuge, the supernatant was 
removed and the cells were suspended in PBS at an OD600 of 0.100. Two milliliters of 
cells were removed and placed in a heat block set at 90 degrees Celsius for 10 minutes. 
These cells acted as a heat-killed positive control. 
The other positive control used was chlorpromazine (CPZ). This was made by 
adding 0.05329 grams (355.33 g/mol) to 1 mL milli Q water to create a concentration of 
150 mM. This solution was suspended and 6 mL was removed and placed in a separate 
tube with 94 mL of milliQ water. This created a CPZ concentration of 9 mM. 
Ethidium bromide was prepared by removing 31.45 mL of 50 mM stock solution 
and diluting it with 1 mL of milliQ water to create a stock solution of 50 mL. This 
solution was kept out of light and in the refrigerator to avoid decomposition. 
All of the prepared solutions were then placed in a black, flat-bottom 96 well 
plate for reading. 180 mL of cells were added to columns 1, 3-12. In column 2 180 mL of 
heat killed cells were added. Next, 10 mL of crude extract was added to columns 4-12. 
To keep the volumes equal 10 mL of water was added to columns 1 and 2. In column 3 
10 mL of CPZ was added. The plate was then inserted for a blank measurement when the 
reader reached 37 degrees Celsius. Measurements were taken at an excitation 
measurement of 515 nm and an emission measurement of 600 nm. (An illustration of this 
is pictured below, Figure 4) The plate reader then ejected the plate and 10 mL of EtBr 
solution was added to all wells. The plate reader was then run taking measurements every 
2 minutes for 30 minutes. This process was repeated for all of the crude extracts. 
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Figure 4: An illustration of the well plate used in the ethidium bromide efflux assay. 
  
The same process as listed above (subheading C) was conducted for all 96 
fractions. Instead of crude sample, 10 mL of each fraction was added. One well was done 
for each fraction instead of eight replications. 
D.  High Performance Liquid Chromatography (HPLC) 
The crude extract was fractionated by high performance liquid chromatography 
(HPLC). A volume of 50 mL of extract was diluted by the addition of 450 mL of milliQ 
water, the solution was clarified by centrifugation at 15,000 rpm for 1 min at room 
temperature and the supernatant was loaded onto a (19 x 50mm) preparatory C18 column 
that had been pre-equilibrated with an aqueous solution of 0.1% trifluoroacetic acid 
(TFA). The column was resolved at 2.5 mL/min using a linear gradient of water plus 
0.1% TFA to methanol plus 0.1% TFA over a period of four hours and 2.5 mL fractions 
were collected. Absorbance was measured at 280 nm. The fractions were placed on small 
glass evaporation dishes and allowed to dry at room temperature. The dried films were 
scraped into 500 mL of MilliQ water and stored in centrifuge tubes at -80 degree Celsius. 
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F. Liquid broth microdilution assay 
A liquid broth microdilution assay was conducted to measure the clinical 
relevance of the efflux assay findings. AG100 E. coli was inoculated into 3 mL of MHB 
and incubated at 37 degrees Celsius overnight. The saturated cultures were used to 
inoculated 25 mL of MHB and the cells were grown to an OD600 of 0.400. The MHB 
used included 10.4 g of MHB powder, 0.0158 g CaCl2, 0.0200 g MgCl2. ML 342 cells 
The cells were incubated until a reading of 0.600 was achieved at OD600. The cells were 
then diluted to an OD600 of 0.100 with MHB (0.5 McFarland). 
Carbenicillin with a starting concentration of 2.9 µg/mL was used to create a 64 
µg/mL stock solution. This was done by adding 0.22 mL of 70 µg/mL carbenicillin to 
978 mL of MilliQ water. 
A 48 well plate was used for this experiment. The experimental wells contained 
300 mL of 0.5 McFarland AG100 E. coli cells in MHB, 87.5 mL of MHB, 50 mL of the 
test compound, and 62.5 mL of 64 µg/mL carbenicillin. The control wells had 300 mL of 
0.5 McFarland AG100 E. coli cells in MHB, 150 mL of MHB, and 50 mL of the test 
compound. Wells containing 137.8 mL of MHB and 62.5 mL of 64 µg/mL carbenicillin 
were also present to compare the extract samples to a normal 8 µg/mL carbenicillin 
growth curve. This plate was then placed in the plate reader at 37 degrees Celsius and an 
absorbance reading was taken at 625 nm every 5 minutes for 16 hours. Before each 
measurement the plate reader was set to shake for 30 seconds to avoid sedimentation. 
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III. Results and Discussion 
 
A. Ethidium Bromide efflux assay of crude extract 
I tested my plant extracts for their ability to block bacterial efflux pumps using an 
ethidium bromide-based efflux assay. EtBr has strong fluorescence properties when 
bound to DNA and it is known to use the efflux pump to exit the cell. A normal, 
uninhibited bacterial cell would efflux the EtBr, which would result in a low fluorescence 
measurement because the EtBr would not accumulate inside the cell. A cell with inhibited 
efflux pumps would be unable to efflux the EtBr out, causing an increased fluorescence 
within the cell. In Figure 5, the water control represents uninhibited cells that pumped 
the EtBr out. CPZ was the positive control that should inhibit efflux pumps. The CPZ 
control shows an increase in inhibition over time. The heat-killed cells should be unable 
to efflux, thus trapping the EtBr in the cell and showing a high level of fluorescence. The 
lemon peel extract shows an increase in fluorescence that mimics that seen by CPZ, 
indicating a significant inhibition of the efflux. All of the other plant extracts that I tested 
failed to cause an increase in fluorescence (data not shown).  
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Figure 5: The line on the bottom is the water control. This flat line near zero indicates efflux by a normal healthy cell. The flat line on 
the top is the heat killed cell. This is showing a cell unable to efflux, therefore the EtBr was trapped in the cell and caused an increase 
in fluorescence. The sloped line in the middle is the CPZ control. This line shows inhibition, and an increase in fluorescence over 
time. The line that slopes towards the top is the lemon peel extract. It follows the same shape of the CPZ, showing increased inhibition 
over time.        
         
B.   HPLC of crude extract 
Several experiments were ran but the crude extract proved to complicate the 
results. The crude extract of lemon peel is a complex mixture that likely contains many 
compounds. My goal was to find out which compound inhibited efflux pump activity. I 
fractionated the crude extract using the HPLC so the proper compounds could be 
identified. The extract was run through the HPLC to separate the compounds to allow for 
accurate readings. The separation resulted in 95 tubes with 2.5 mL of clear solution in 
them. The HPLC took readings of the sample at 280 nm as it was leaving the column. 
The chromatogram below (Figure 6) shows the HPLC results. 
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
Figure 6: The HPLC chromatogram shows peak measured at 280 nm. The asterisks represent the active fractions found in 
the crude lemon peel extract. 
 
C. Ethidium Bromide efflux assay of HPLC separated compounds 
Each HPLC fraction was tested in the ethidium bromide-based efflux assay. The 
same controls as before were used. The overall difference in fluorescence from t = 0 to t 
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= 30 min for each compound is shown in a bar graph below (Figure 7). An increase of 
fluorescence, as indicated before, is a way of showing inhibition of the efflux pump. As 
shown, some lines barely increased in RFU and were excluded from the remainder of 
experiments. HPLC fractions 9, 24, 68, and 72 produce an increase in fluorescence that 
appeared to be greater than that of the other fractions so they were chosen for further 
study.  
Figure 7: This bar graph shows the difference in fluorescence measurement from start to finish of the EtBr efflux assay for each 
compound. The compounds with the greatest increase indicate the greatest inhibition and were used for future experiments. 
 
D.   Broth microdilution assay results 
The EtBr efflux assay provided information on the extract’s ability to visualize 
efflux activity, but does not provide much insight on the clinical relevance of this 
methodology. The liquid broth microdilution assays allowed for the testing of antibiotic 
accumulation in the cell to test the clinical relevance of the extract in sensitizing the cell 
to antibiotic. Concentrations of the antibiotic carbenicillin were measured for use in the 
experiment. A growth curve that most mimicked an “S”-shaped cell growth curve was 
selected for. In the graph below (Figure 8), the concentration of carbenicillin can be 
observed. A concentration of 24 µg/mL resulted in a flat line from start to finish (bottom 
curve in Figure 8). The absence of carbenicillin results in a normal, uninterrupted cell 
growth curve (top curve in Figure 8). For my experiment, I was looking for a growth 
curve that showed cell death by antibiotic, but also mimicked a normal curve so that a 
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change in cell proliferation could be observed. A concentration of 8 µg/mL carbenicillin 
was chosen because of its effect on cell death as well as its ability to show a change in 
cell growth curve with differences in inhibition.  
Figure 8: This graph shows the experimental testing of concentrations of carbenicillin in the presence of E. coli cells. The line on the 
bottom is a concentration of 24 µg/mL and shows complete cell death. The line on the top is a concentration of 0 µg/mL of 
carbenicillin, this shows a regular cell growth curve. For my experiments I used the 8 µg/mL concentration. This concentration of 
carbenicillin mimics a regular cell growth curve, as well as allows for measurement of inhibition and the increase or decrease of cell 
death in the presence of the lemon peel compounds. 
        This concentration, alongside lemon peel compounds, was tested in a liquid broth 
microdilution test. Each compound was tested alone with  E. coli, as well as alongside 8 
µg/mL carbenicillin to show a shift in growth curve. With successful inhibition, the 
growth curve of the cells in antibiotic and extract would be shifted right, indicating 
decreased cell growth. 
In Figure 9, it can be seen that the growth curve of the E. coli was shifted right, 
indicating increased inhibition in the presence of this compound. This graph shows the 
inhibition of efflux in the cells, causing the cells to become more sensitive to the 
antibiotic, resulting in cell death. This result further indicates the success of lemon peel 
extract in inhibiting the efflux of E. coli cells, implying further the clinical relevance of 
these compounds in combating antibiotic resistance. 
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Figure 9: This graph shows the cell growth curves of E. coli. The top curve is cells with compound 9. This should be a regular cell 
exhibiting a regular cell growth curve. The middle line is the cells with 8 µg/mL carbenicillin. This is the standard curve used to 
compare the effects of the compounds alongside antibiotic. The bottom line shows this. The curve shows a rightward shift, indicating 
increased sensitization to the antibiotic, and cell death. 
The same result as before can be seen in the following graphs (Figure 10, Figure 
11, Figure 12). Compound 24 caused the cell to become more sensitized to the antibiotic 
and resulted in an increase in cell death. 
Figure 10: This graph shows the cell growth curves of  E. coli. The top curve is cells with compound 24. This should be a regular cell 
exhibiting a regular cell growth curve. The middle line is the cells with 8 µg/mL carbenicillin. This is the standard curve used to 
compare the effects of the compounds alongside antibiotic. The bottom line shows this. The curve shows a rightward shift, indicating 
increased sensitization to the antibiotic, and cell death. 
Compound 68, as seen in Figure 11, caused the cell to become more sensitized to 
the antibiotic and resulted in an increase in cell death. 
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Figure 11: This graph shows the cell growth curves of E. coli. The top curve is cells with compound 68. This should be a regular cell 
exhibiting a regular cell growth curve. The middle line is the cells with 8 µg/mL carbenicillin. This is the standard curve used to 
compare the effects of the compounds alongside antibiotic. The bottom line shows this. The curve shows a rightward shift, indicating 
increased sensitization to the antibiotic, and cell death. 
Compound 72, as shown in Figure 12, caused the cell to become more sensitized 
to the antibiotic and resulted in an increase in cell death. 
Figure 12: This graph shows the cell growth curves of E. coli. The top curve is cells with compound 72. This should be a regular cell 
exhibiting a regular cell growth curve. The middle line is the cells with 8 µg/mL carbenicillin. This is the standard curve used to 
compare the effects of the compounds alongside antibiotic. The bottom line shows this. The curve shows a rightward shift, indicating 
increased sensitization to the antibiotic, and cell death. 
E. Conclusions
The results of my experiment show the ability of lemon peel extract to inhibit the 
efflux pump of E. coli bacteria. Using this information, the compounds of lemon peel 
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extract were tested for clinical relevance. The results of utilizing lemon peel to inhibit the 
pump, as well as antibiotic to interfere with cell proliferation were successful. The results 
of these tests indicate the ability of the compounds in lemon peel to sensitize the cell to 
antibiotic and aid in combating antibiotic resistance. 
Future research should be aimed at identifying the compounds in HPLC fractions 
9, 24, 68, and 72. I could be the case that these are four different compounds, or 
potentially the same parent compound that may have several variant forms. Research in 
the future could also be done to determine the cytotoxicity of the lemon peel extract in 
crude form, as well as each of the individual compounds from HPLC fractionation. 
Future research should also be done to determine the overall mechanism of action that 
lemon peel extract compounds use in increasing the sensitivity of bacterial cells to 
antibiotics. This can be done by testing cells without TolC, one of the proteins involved 
in efflux, to determine if the lemon peel extract inhibits that pump directly. 
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